Palisade Bio Investor Relations Material
Latest events
Q1 2025
11 May, 2025
Q4 2024
24 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Palisade Bio Inc
Access all reports
Palisade Bio Inc is a U.S.-based clinical-stage biopharmaceutical company developing therapeutics for gastrointestinal health. The company focuses on reducing post-surgical complications and improving recovery outcomes through targeted enzyme inhibitors. It collaborates with research institutions and conducts clinical trials to advance its drug candidates. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
)
)
)